Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Seres Therapeutics to Participate in Three Upcoming November Conferences

Seres Therapeutics,Inc.
Posted on: 08 Nov 17

Seres Therapeutics, Inc., (NASDAQ:MCRB) today announced that it will participate in each of the following upcoming healthcare conferences:

  • Stifel 2017 Healthcare Conference: A corporate overview will be presented on Tuesday, November 14 at 5:00 p.m. ET in New York, NY.
  • 29 th Annual Piper Jaffray Healthcare Conference: A corporate overview will be presented on Wednesday, November 29 at 10:30 a.m. ET in New York, NY.
  • Evercore ISI Biopharma Catalyst/Deep Dive Conference: Members of the management team will participate in one-on-one meetings on Thursday, November 30 in Boston, MA.

A live audio webcast of each presentation will be available under the “Investors and Media” section of Seres’ website. A replay of the presentation will become available approximately one hour after the event and will be archived for 21 days.

About Seres Therapeutics

Seres Therapeutics, Inc., is a leading microbiome therapeutics platform Company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, where the natural state of bacterial diversity and function is imbalanced. Seres’ lead program, SER-109, has obtained Breakthrough Therapy and Orphan Drug designations from the U.S. Food and Drug Administration and is in Phase 3 development for multiply recurrent C. difficile infection. Seres’ clinical candidate SER-287 has successfully completed a Phase 1b study in patients with mild-to-moderate Ulcerative Colitis. Seres is also developing SER-262, the first ever synthetic microbiome therapeutic candidate, in a Phase 1b study in patients with primary C. difficile infection. For more information, please visit www.serestherapeutics.com. Follow us on Twitter @SeresTx.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005134/en/

Business Wire
www.businesswire.com

Last updated on: 08/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.